MLTX - Latest News
MoonLake Immunotherapeutics (MLTX), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $1.46B. Beta to the broader market is 1.04.
The article list below shows the most recent MLTX headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent MLTX Headlines
MoonLake: 'Buy' Sonelokimab BLA Submission HS September And Label Expansion
seekingalpha.com - Jun 26, 2026
MoonLake Immunotherapeutics maintains a Buy rating, supported by positive FDA interactions and strong long-term data for sonelokimab in hidradenitis s
Why MoonLake Immunotherapeutics Stock Wilted on Wednesday
fool.com - Jun 24, 2026
It aims to raise up to $200 million in the offering. This will support its efforts to bring its top drug candidate to market.
MoonLake Immunotherapeutics Announces Pricing of Upsized $200 Million Public Offering
globenewswire.com - Jun 23, 2026
ZUG, Switzerland, June 23, 2026 – MoonLake Immunotherapeutics (NASDAQ: MLTX) (“MoonLake”), a clinical-stage biotechnology company focused on creating
MoonLake Immunotherapeutics: Label Upside Drives The Next Leg Higher
seekingalpha.com - Jun 23, 2026
MoonLake Immunotherapeutics is positioned for upside on differentiated efficacy and a large, underpenetrated hidradenitis suppurativa, or HS, market.
MoonLake Immunotherapeutics Announces Proposed Public Offering
globenewswire.com - Jun 22, 2026
ZUG, Switzerland, June 22, 2026 – MoonLake Immunotherapeutics (NASDAQ: MLTX) (“MoonLake”), a clinical-stage biotechnology company focused on creating
How News Affects MLTX Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track MLTX's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked MLTX news questions
- What is the latest MLTX news headline?
- The most recent MLTX headline (Jun 26, 2026) is "MoonLake: 'Buy' Sonelokimab BLA Submission HS September And Label Expansion". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the MLTX news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What MLTX news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual MLTX options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.